Lawrenceville, NJ, United States of America

Heather J Finlay

This inventor holds 45 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 23 EPO patents, primarily in Potassium Ion Channel Inhibitors. Top assignees: Bristol-Myers Squibb Compnay, Icagen, Inc.. Active years: 2000-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Heather J Finlay. Retrieved from https://idiyas.com/inventor/heather-j-finlay

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 45 (Patent Applications = 2)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 23 (Patent Applications = 21)

Average Co-Inventor Count = 6.6

ph-index = 8

Forward Citations = 393(Granted Patents)

Location History:

Lawrenceville, NJ (US) (2000 - 2009)
Skillman, NJ (US) (2006 - 2022)

Company Filing History:

45 out of 3,745

Bristol-Myers Squibb Compnay

where one patent can have more than one assignee

Years Active: 2000-2024

Loading Chart...

Areas of Expertise:

Potassium Ion Channel

Endothelial Lipase

APJ Receptor Agonists

Quinazolines

Heteroarylhydroxypyrimidinones

Pyrrolinone Carboxamide

Heterocyclic CETP

Inhibitors

Dihydropyrimidine

Benzothiazole

Pyrrolopyridazines

Phthalazines

45 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12168655 - Apelin receptor agonists and methods of use (2024-12-17),

2. 11390616 - Apelin receptor agonists and methods of use (2022-07-19),

3. 11008306 - Quinazolines as potassium ion channel inhibitors (2021-05-18),

4. 10889565 - 4-hydroxy-3-sulfonylpyridin-2(1H)-ones as APJ receptor agonists (2021-01-12),

5. 10676460 - Quinazolines as potassium ion channel inhibitors (2020-06-09),

6. 10669261 - Heteroarylhydroxypyrimidinones as agonists of the APJ receptor (2020-06-02),

7. 10597370 - 2-(benzothiazol-2-yl)-2-cyano-acetamide derivatives and their use as endothelial lipase inhibitors (2020-03-24),

8. 10590113 - 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonists (2020-03-17),

9. 10508104 - 6-hydroxy-5-(phenyl/heteroarylsulfonyl)pyrimidin-4(1H)-one as APJ agonists (2019-12-17),

10. 10392347 - 2,4-dihydroxy-nicotinamides as APJ agonists (2019-08-27),

11. 10214511 - Quinazolines as potassium ion channel inhibitors (2019-02-26),

12. 10173991 - Sulfone amide linked benzothiazole inhibitors of endothelial lipase (2019-01-08),

13. 10106528 - 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonists (2018-10-23),

14. 9822096 - Quinazolines as potassium ion channel inhibitors (2017-11-21),

15. 9493412 - Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors (2016-11-15),

Title: Heather J Finlay - Innovative Inventor from Lawrenceville

Introduction: Heather J Finlay is a pioneering inventor based in Lawrenceville, NJ, known for her groundbreaking contributions to various industries.

Latest Patents: Heather J Finlay holds several patents in the fields of technology, healthcare, and sustainability, showcasing her diverse range of expertise and innovative thinking.

Career Highlights: With a career spanning over two decades, Heather J Finlay has consistently pushed the boundaries of innovation, leading to the development of cutting-edge solutions that have positively impacted society.

Collaborations: Throughout her career, Heather J Finlay has collaborated with leading research institutions, universities, and companies to further enhance her inventions and bring them to the market, solidifying her reputation as a visionary inventor.

Conclusion: Heather J Finlay's passion for innovation and her relentless drive to create solutions for the future make her a standout figure in the world of inventors, inspiring the next generation of innovators to think outside the box.

Profile summary based on public USPTO records.